The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
22721392
DOI
10.2174/1871520611313050015
PII: CMCACA-EPUB-20120618-10
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků fyziologie MeSH
- autofagie účinky léků fyziologie MeSH
- buňky HT-29 MeSH
- fytogenní protinádorové látky farmakologie terapeutické užití MeSH
- HCT116 buňky MeSH
- irinotekan MeSH
- kamptothecin analogy a deriváty farmakologie terapeutické užití MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 nedostatek genetika MeSH
- nádory tračníku farmakoterapie genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fytogenní protinádorové látky MeSH
- irinotekan MeSH
- kamptothecin MeSH
- nádorový supresorový protein p53 MeSH
The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
Citace poskytuje Crossref.org